Nobiletin ameliorates neurodegeneration in a mouse model of STZ-induced AD via stimulating autophagy through activating SIRT1/FoxO3a pathway, blocking the phosphorylation of Akt and its inhibiting downstream targets to control the inflammatory response and oxidative stress, and to control the cholinergic system. The gene discussed is AKT1; the disease is Alzheimer disease.